Home

Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 25/03/27

Trade details

Type
Insider sale
Amount
$8,135.79
Shares · price
907 sh · $8.97 a share
Held after
1,925 sh
Trade date
25/03/26
Filed
25/03/27
Days to filing
1 days

Sold 32.0% of holdings

Share of holding sold
32.0%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/24~25/04/25

Brett R. Hagen's recent trades

  • Brett R. Hagen

    SellKalaris Therapeutics

    $12.9K

    Filed 03/23

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $12.9K

    Filed 03/20

  • Brett R. Hagen

    SellKalaris Therapeutics

    $968

    Filed 25/02/24

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $967

    Filed 25/02/24

  • Brett R. Hagen

    SellKalaris Therapeutics

    $302

    Filed 25/01/27